{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:22:09Z","timestamp":1792981329851,"version":"4.5.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bleeding disorders, including von Willebrand disease (VWD), hemophilia, other coagulation factor deficiencies, platelet disorders, defects of fibrinolysis, and connective tissue disorders, have both maternal and fetal implications. Successful management of bleeding disorders in pregnant women requires not only an understanding of bleeding disorders but also an understanding of when and how bleeding occurs in pregnancy. Bleeding does not occur during a normal pregnancy with a healthy placenta. Bleeding occurs during pregnancy when there is an interruption of the normal utero-placental interface, during miscarriage, during an ectopic pregnancy, or at the time of placental separation at the conclusion of pregnancy. Although mild platelet defects may be more prevalent, the most commonly diagnosed bleeding disorder among women is VWD. Other bleeding disorders are less common, but hemophilia carriers are unique in that they are at risk of bleeding themselves and of giving birth to an affected male infant. General guidance for maternal management of a woman who is moderately or severely affected includes obtaining coagulation factor levels at a minimum in the third trimester; planning for delivery at a center with hemostasis expertise; and anticipating the need for hemostatic agents. General guidance for fetal management includes pre-pregnancy counseling; the option of preimplantation genetic testing for hemophilia; delivery at a tertiary care center with pediatric hematology and newborn intensive care; consideration of cesarean delivery of a potentially severely affected infant; and avoidance of invasive procedures such as scalp electrodes and operative vaginal delivery in any potentially affected infant.<\/jats:p>","DOI":"10.1182\/hematology.2023000475","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T10:08:37Z","timestamp":1702030117000},"page":"229-236","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Management of pregnant women who have bleeding disorders"],"prefix":"10.1182","volume":"2023","author":[{"given":"Andra H.","family":"James","sequence":"first","affiliation":[{"name":"1 Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology; and Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis D.","family":"Pacheco","sequence":"additional","affiliation":[{"name":"2 Divisions of Maternal Fetal Medicine and Surgical Critical Care, Departments of Obstetrics, Gynecology, and Anesthesiology, University of Texas Medical Branch, Galveston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[{"name":"3 Washington Center for Bleeding Disorders, Division of Hematology, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"2","key":"2023120815054297600_hem2023000475C1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"2023120815054297600_hem2023000475C2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/hae.14257","article-title":"Incidence of von Willebrand disease in Denmark, 1995-2016: a cohort study","volume":"27","author":"Laursen","year":"2021","journal-title":"Haemophilia"},{"issue":"6","key":"2023120815054297600_hem2023000475C3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2023120815054297600_hem2023000475C4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2023120815054297600_hem2023000475C5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"6","key":"2023120815054297600_hem2023000475C6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"issue":"5","key":"2023120815054297600_hem2023000475C7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1365-2516.2010.02210.x","article-title":"How many carriers are there?","volume":"16","author":"Kasper","year":"2010","journal-title":"Haemophilia"},{"issue":"suppl 2","key":"2023120815054297600_hem2023000475C8","first-page":"S45","article-title":"National and international registries of rare bleeding disorders","volume":"6","author":"Peyvandi","year":"2008","journal-title":"Blood Transfus"},{"issue":"3","key":"2023120815054297600_hem2023000475C9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/jwh.2022.0008","article-title":"Bleeding disorders in women and girls: state of the science and CDC collaborative programs","volume":"31","author":"Byams","year":"2022","journal-title":"J Women's Health"},{"issue":"11","key":"2023120815054297600_hem2023000475C10","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1111\/j.1537-2995.2009.02318.x","article-title":"Blood component therapy in postpartum hemorrhage","volume":"49","author":"James","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"2023120815054297600_hem2023000475C11","doi-asserted-by":"crossref","first-page":"12.e1","DOI":"10.1016\/j.ajog.2009.04.024","article-title":"Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel","volume":"201","author":"James","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"2023120815054297600_hem2023000475C12","first-page":"S16","article-title":"Postpartum hemorrhage: when uterotonics and sutures fail","volume":"87","author":"James","year":"2012","journal-title":"Am J Hematol"},{"issue":"2","key":"2023120815054297600_hem2023000475C13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2516.2006.01413.x","article-title":"Is primary postpartum haemorrhage a good predictor of inherited bleeding disorders?","volume":"13","author":"Kadir","year":"2007","journal-title":"Haemophilia"},{"issue":"5","key":"2023120815054297600_hem2023000475C14","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1213\/ANE.0000000000004424","article-title":"Trends in postpartum hemorrhage in the United States from 2010 to 2014","volume":"130","author":"Reale","year":"2020","journal-title":"Anesth Analg"},{"issue":"1","key":"2023120815054297600_hem2023000475C15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"11","key":"2023120815054297600_hem2023000475C16","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"Drury-Stewart","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"2023120815054297600_hem2023000475C17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.thromres.2011.08.023","article-title":"Obesity- related coagulation changes in pregnancy","volume":"129","author":"Smrtka","year":"2012","journal-title":"Thromb Res"},{"issue":"5-6","key":"2023120815054297600_hem2023000475C18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"issue":"1","key":"2023120815054297600_hem2023000475C19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"2023120815054297600_hem2023000475C20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00132582-198312000-00003","article-title":"Platelets in pregnancy: hyperdestruction in pregnancy","volume":"3","author":"Fay","year":"1983","journal-title":"Obstet Anesth Dig"},{"issue":"13","key":"2023120815054297600_hem2023000475C21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/1471-0528.12394","article-title":"Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study","volume":"120","author":"Burke","year":"2013","journal-title":"BJOG"},{"issue":"1","key":"2023120815054297600_hem2023000475C22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2023120815054297600_hem2023000475C23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2516.1999.00302.x","article-title":"Hereditary pseudohaemophilia","volume":"5","author":"Von Willebrand","year":"1999","journal-title":"Haemophilia"},{"issue":"3","key":"2023120815054297600_hem2023000475C24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2023120815054297600_hem2023000475C25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-0528.2008.01859.x","article-title":"Prevalence and risk factors of severe obstetric haemorrhage","volume":"115","author":"Al-Zirqi","year":"2008","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"2023120815054297600_hem2023000475C26","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with von Willebrand disease: a systematic review","volume":"39","author":"Punt","year":"2020","journal-title":"Blood Rev"},{"issue":"2","key":"2023120815054297600_hem2023000475C27","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/hae.14186","article-title":"Genetic causes of haemophilia in women and girls","volume":"27","author":"Miller","year":"2021","journal-title":"Haemophilia"},{"issue":"8","key":"2023120815054297600_hem2023000475C28","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/jth.15397","article-title":"A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH","volume":"19","author":"van Galen","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"suppl 3","key":"2023120815054297600_hem2023000475C29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/hae.14094","article-title":"Women and girls with haemophilia: lessons learned","volume":"27","author":"d'Oiron","year":"2021","journal-title":"Haemophilia"},{"issue":"suppl","key":"2023120815054297600_hem2023000475C30","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.blre.2021.100826","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: a systematic review","volume":"49","author":"Punt","year":"2021","journal-title":"Blood Rev"},{"issue":"6","key":"2023120815054297600_hem2023000475C31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.hoc.2021.07.012","article-title":"Factor XI deficiency","volume":"35","author":"Lewandowska","year":"2021","journal-title":"Hematol\/Oncol Clin North Am"},{"issue":"10","key":"2023120815054297600_hem2023000475C32","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/bloodadvances.2022008648","article-title":"Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study","volume":"7","author":"Handa","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"2023120815054297600_hem2023000475C33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.12856","article-title":"Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review","volume":"22","author":"Wiewel-Verschueren","year":"2016","journal-title":"Haemophilia"},{"issue":"4","key":"2023120815054297600_hem2023000475C34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/hae.14086","article-title":"Management of pregnancy in women with factor VII deficiency: a case series","volume":"26","author":"Lee","year":"2020","journal-title":"Haemophilia"},{"issue":"suppl 2","key":"2023120815054297600_hem2023000475C35","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(13)70004-5","article-title":"Epidemiology and treatment of congenital fibrinogen deficiency","volume":"130","author":"Peyvandi","year":"2012","journal-title":"Thromb Res"},{"issue":"4","key":"2023120815054297600_hem2023000475C36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2023120815054297600_hem2023000475C37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2020.04.010","article-title":"Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency","volume":"191","author":"Rugeri","year":"2020","journal-title":"Thromb Res"},{"issue":"6","key":"2023120815054297600_hem2023000475C38","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"Sharief","year":"2013","journal-title":"Haemophilia"},{"issue":"17","key":"2023120815054297600_hem2023000475C39","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.2021011595","article-title":"How I manage pregnancy in women with Glanzmann thrombasthenia","volume":"139","author":"Fiore","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2023120815054297600_hem2023000475C40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2516.2009.02137.x","article-title":"Bernard Soulier syndrome in pregnancy: a systematic review","volume":"16","author":"Peitsidis","year":"2010","journal-title":"Haemophilia"},{"issue":"12","key":"2023120815054297600_hem2023000475C41","doi-asserted-by":"crossref","first-page":"e27376","DOI":"10.1002\/pbc.27376","article-title":"From thrombasthenia to next generation thrombocytopenia: neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia","volume":"65","author":"Barg","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2023120815054297600_hem2023000475C42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/AOG.0b013e31823403f4","article-title":"Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification","volume":"118","author":"Pacheco","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"10084","key":"2023120815054297600_hem2023000475C43","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post- partum haemorrhage (WOMAN): an international, randomised, double- blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2023120815054297600_hem2023000475C44","doi-asserted-by":"crossref","first-page":"85.e1","DOI":"10.1016\/j.ajog.2020.11.035","article-title":"Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women","volume":"225","author":"Ahmadzia","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2023120815054297600_hem2023000475C45","unstructured":"Tranexamic acid. Drugs and Lactation Database (LactMed). National Institute of Child Health and Human Development; 2006. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/. Accessed July12, 2023."},{"issue":"8","key":"2023120815054297600_hem2023000475C46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/bfm.2014.0027","article-title":"Outcome following tranexamic acid exposure during breastfeeding","volume":"9","author":"Gilad","year":"2014","journal-title":"Breastfeed Med"},{"issue":"1","key":"2023120815054297600_hem2023000475C47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2011.02573.x","article-title":"A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy","volume":"18","author":"Trigg","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"2023120815054297600_hem2023000475C48","first-page":"301","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021"},{"issue":"12","key":"2023120815054297600_hem2023000475C49","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","article-title":"Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series","volume":"29","author":"Achinger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"19","key":"2023120815054297600_hem2023000475C50","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","volume":"136","author":"Leebeek","year":"2020","journal-title":"Blood"},{"issue":"7","key":"2023120815054297600_hem2023000475C51","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/jth.15770","article-title":"JTH in clinic - obstetric bleeding: VWD and other inherited bleeding disorders","volume":"20","author":"Johnsen","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"suppl 6","key":"2023120815054297600_hem2023000475C52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"1","key":"2023120815054297600_hem2023000475C53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/hae.12726","article-title":"Mode of delivery and cranial bleeding in newborns with haemophilia: a systematic review and meta-analysis of the literature","volume":"22","author":"Davies","year":"2016","journal-title":"Haemophilia"},{"issue":"10","key":"2023120815054297600_hem2023000475C54","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3324\/haematol.2018.209619","article-title":"Mode of delivery in hemophilia: vaginal delivery and cesarean section carry similar risks for intracranial hemorrhages and other major bleeds","volume":"104","author":"Andersson","year":"2019","journal-title":"Haematologica"},{"issue":"9239","key":"2023120815054297600_hem2023000475C55","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(00)02840-3","article-title":"Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group","volume":"356","author":"Hannah","year":"2000","journal-title":"Lancet"},{"issue":"14","key":"2023120815054297600_hem2023000475C56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1214939","article-title":"A randomized trial of planned cesarean or vaginal delivery for twin pregnancy","volume":"369","author":"Barrett","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2023120815054297600_hem2023000475C57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jtha.2022.11.009","article-title":"High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study","volume":"21","author":"Maas","year":"2023","journal-title":"J Thromb Haemost"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/229\/2175618\/229james.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2023\/1\/229\/2175618\/229james.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T10:08:57Z","timestamp":1702030137000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2023\/1\/229\/506414\/Management-of-pregnant-women-who-have-bleeding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2023,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2023000475","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,8]]},"published":{"date-parts":[[2023,12,8]]}}}